Genotype-phenotype relationships in ataxia-telangiectasia and variants - PubMed (original) (raw)
Genotype-phenotype relationships in ataxia-telangiectasia and variants
S Gilad et al. Am J Hum Genet. 1998 Mar.
Abstract
Ataxia-telangiectasia (A-T) is an autosomal recessive disorder characterized by cerebellar degeneration, immunodeficiency, chromosomal instability, radiosensitivity, and cancer predisposition. A-T cells are sensitive to ionizing radiation and radiomimetic chemicals and fail to activate cell-cycle checkpoints after treatment with these agents. The responsible gene, ATM, encodes a large protein kinase with a phosphatidylinositol 3-kinase-like domain. The typical A-T phenotype is caused, in most cases, by null ATM alleles that truncate or severely destabilize the ATM protein. Rare patients with milder manifestations of the clinical or cellular characteristics of the disease have been reported and have been designated "A-T variants." A special variant form of A-T is A-TFresno, which combines a typical A-T phenotype with microcephaly and mental retardation. The possible association of these syndromes with ATM is both important for understanding their molecular basis and essential for counseling and diagnostic purposes. We quantified ATM-protein levels in six A-T variants, and we searched their ATM genes for mutations. Cell lines from these patients exhibited considerable variability in radiosensitivity while showing the typical radioresistant DNA synthesis of A-T cells. Unlike classical A-T patients, these patients exhibited 1%-17% of the normal level of ATM. The underlying ATM genotypes were either homozygous for mutations expected to produce mild phenotypes or compound heterozygotes for a mild and a severe mutation. An A-TFresno cell line was found devoid of the ATM protein and homozygous for a severe ATM mutation. We conclude that certain "A-T variant" phenotypes represent ATM mutations, including some of those without telangiectasia. Our findings extend the range of phenotypes associated with ATM mutations.
Similar articles
- Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity.
Becker-Catania SG, Chen G, Hwang MJ, Wang Z, Sun X, Sanal O, Bernatowska-Matuszkiewicz E, Chessa L, Lee EY, Gatti RA. Becker-Catania SG, et al. Mol Genet Metab. 2000 Jun;70(2):122-33. doi: 10.1006/mgme.2000.2998. Mol Genet Metab. 2000. PMID: 10873394 - Ataxia-telangiectasia: mild neurological presentation despite null ATM mutation and severe cellular phenotype.
Alterman N, Fattal-Valevski A, Moyal L, Crawford TO, Lederman HM, Ziv Y, Shiloh Y. Alterman N, et al. Am J Med Genet A. 2007 Aug 15;143A(16):1827-34. doi: 10.1002/ajmg.a.31853. Am J Med Genet A. 2007. PMID: 17632790 - Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia.
Hassin-Baer S, Bar-Shira A, Gilad S, Galanty Y, Khosravi R, Lossos A, Giladi N, Weitz R, Ben-Zeev B, Goldhammer Y, Shiloh Y. Hassin-Baer S, et al. J Neurol. 1999 Aug;246(8):716-9. doi: 10.1007/s004150050438. J Neurol. 1999. PMID: 10460451 Clinical Trial. - ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.
Lavin MF, Khanna KK. Lavin MF, et al. Int J Radiat Biol. 1999 Oct;75(10):1201-14. doi: 10.1080/095530099139359. Int J Radiat Biol. 1999. PMID: 10549596 Review. - Radiosensitivity and oxidative signalling in ataxia telangiectasia: an update.
Lavin MF. Lavin MF. Radiother Oncol. 1998 May;47(2):113-23. doi: 10.1016/s0167-8140(98)00027-9. Radiother Oncol. 1998. PMID: 9683357 Review.
Cited by
- Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO).
Cavalieri S, Pozzi E, Gatti RA, Brusco A. Cavalieri S, et al. Eur J Hum Genet. 2013 Jul;21(7):774-8. doi: 10.1038/ejhg.2012.266. Epub 2012 Dec 5. Eur J Hum Genet. 2013. PMID: 23211698 Free PMC article. - ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes.
Delia D, Mizutani S, Panigone S, Tagliabue E, Fontanella E, Asada M, Yamada T, Taya Y, Prudente S, Saviozzi S, Frati L, Pierotti MA, Chessa L. Delia D, et al. Br J Cancer. 2000 Jun;82(12):1938-45. doi: 10.1054/bjoc.2000.1168. Br J Cancer. 2000. PMID: 10864201 Free PMC article. - Chromosome instability and oxidative stress markers in patients with ataxia telangiectasia and their parents.
Ludwig LB, Valiati VH, Palazzo RP, Jardim LB, da Rosa DP, Bona S, Rodrigues G, Marroni NP, Prá D, Maluf SW. Ludwig LB, et al. Biomed Res Int. 2013;2013:762048. doi: 10.1155/2013/762048. Epub 2013 Jul 9. Biomed Res Int. 2013. PMID: 23936845 Free PMC article. - ATM Kinase Dead: From Ataxia Telangiectasia Syndrome to Cancer.
Putti S, Giovinazzo A, Merolle M, Falchetti ML, Pellegrini M. Putti S, et al. Cancers (Basel). 2021 Nov 1;13(21):5498. doi: 10.3390/cancers13215498. Cancers (Basel). 2021. PMID: 34771661 Free PMC article. Review. - A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.
Campbell A, Krupp B, Bushman J, Noble M, Pröschel C, Mayer-Pröschel M. Campbell A, et al. Hum Mol Genet. 2015 Nov 15;24(22):6331-49. doi: 10.1093/hmg/ddv342. Epub 2015 Aug 26. Hum Mol Genet. 2015. PMID: 26310626 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1980 Dec;77(12):7315-7 - PubMed
- Int J Radiat Biol. 1994 Dec;66(6 Suppl):S87-96 - PubMed
- Nucleic Acids Res. 1982 Jan 22;10(2):459-72 - PubMed
- Cytogenet Cell Genet. 1981;31(4):203-13 - PubMed
- J Neurol Sci. 1984 Nov-Dec;66(2-3):307-17 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous